Ionis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of…

Biotechnology
US, Carlsbad [HQ]
IONS/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of IONS's Analysis
CIK: 874015 CUSIP: 462222100 ISIN: US4622221004 LEI: - UEI: -
Secondary Listings
IONS has no secondary listings inside our databases.